10% Owner Converts $7.2M in Pre-Funded Warrants to Common Stock at 50% Discount
Summary
Domicilium Real Estate Fund III LP, a 10% owner, converted $7.2 million worth of pre-funded warrants into 1,200,000 common shares at an implied price of $6.00 per share, a 50% discount to the current market price.
Key Events · Ownership and Investor Activity · ELOX
-
Warrant Conversion
Domicilium Real Estate Fund III LP, a 10% owner, converted pre-funded warrants into 1,200,000 shares of common stock on June 10, 2026.
-
Significant Value & Dilution
The converted shares represent a value of $7.2 million, equivalent to approximately $6.00 per share, which is a 50% discount to the current market price. This conversion adds a substantial number of shares to the outstanding float.
-
Insider Ownership Change
This transaction increases the 10% owner's direct holdings of common stock to 834,489 shares, following recent public offerings that included pre-funded warrants.
Analysis · ELOX · Life Sciences
This Form 4 reports that Domicilium Real Estate Fund III LP, a 10% owner, converted pre-funded warrants into 1,200,000 shares of common stock on June 10, 2026. This transaction, valued at $7.2 million, is a mechanical conversion of previously acquired derivative securities rather than an open-market purchase. The implied conversion price of approximately $6.00 per share is at a significant 50% discount to the current market price of $12.00. This event follows recent public offerings by Eloxx Pharmaceuticals that included pre-funded warrants, indicating the conversion of these instruments into common shares. While it increases the insider's direct common stock holdings, it also adds a substantial number of shares to the outstanding float, which is dilutive for existing shareholders.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ELOX was trading at $12.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $587.1K. The 52-week trading range was $0.02 to $17.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.